Taegtmeyer, A. B., Leuppi, J. and Kullak-Ublick, G. (2012) “Roflumilast – a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD”, Swiss Medical Weekly, 142(2930), p. w13628. doi: 10.4414/smw.2012.13628.